Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Steven L, Gonias"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract LDL Receptor-related Protein-1 (LRP1/CD91) binds diverse ligands, many of which activate cell-signaling. Herein, we compared three LRP1 ligands that inhibit inflammatory responses triggered by lipopolysaccharide (LPS), including: enzymatical
Externí odkaz:
https://doaj.org/article/c31b59cff4f44999a6c4969dc1801bc6
Autor:
Elisabetta Mantuano, Carlotta Zampieri, Pardis Azmoon, Cory B. Gunner, Kyle R. Heye, Steven L. Gonias
Publikováno v:
JCI Insight, Vol 8, Iss 15 (2023)
Low-density lipoprotein receptor-related protein-1 (LRP1) functions as a receptor for nonpathogenic cellular prion protein (PrPC), which is released from cells by ADAM (a disintegrin and metalloproteinase domain) proteases or in extracellular vesicle
Externí odkaz:
https://doaj.org/article/afe55472c9374d5caabfd913552ed274
Autor:
Steven L Gonias, Wendy M Campana
Publikováno v:
Neural Regeneration Research, Vol 18, Iss 2, Pp 325-326 (2023)
Externí odkaz:
https://doaj.org/article/4eeb397eb25249c3b9e4f5f45ff30287
Autor:
Paola Pontecorvi, Michael A. Banki, Carlotta Zampieri, Cristina Zalfa, Pardis Azmoon, Maria Z. Kounnas, Cinzia Marchese, Steven L. Gonias, Elisabetta Mantuano
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Abstract Background Astrocytes contribute to the crosstalk that generates chronic neuro-inflammation in neurological diseases; however, compared with microglia, astrocytes respond to a more limited continuum of innate immune system stimulants. Recent
Externí odkaz:
https://doaj.org/article/c67ad0f1890e467e9e9e93cdbf827933
Autor:
Cory B. Gunner, Pardis Azmoon, Elisabetta Mantuano, Lipsa Das, Carlotta Zampieri, Salvatore V. Pizzo, Steven L. Gonias
Publikováno v:
Journal of Cellular Biochemistry. 124:743-752
Autor:
Smruthi Karthikeyan, Joshua I. Levy, Peter De Hoff, Greg Humphrey, Amanda Birmingham, Kristen Jepsen, Sawyer Farmer, Helena M. Tubb, Tommy Valles, Caitlin E. Tribelhorn, Rebecca Tsai, Stefan Aigner, Shashank Sathe, Niema Moshiri, Benjamin Henson, Adam M. Mark, Abbas Hakim, Nathan A. Baer, Tom Barber, Pedro Belda-Ferre, Marisol Chacón, Willi Cheung, Evelyn S. Cresini, Emily R. Eisner, Alma L. Lastrella, Elijah S. Lawrence, Clarisse A. Marotz, Toan T. Ngo, Tyler Ostrander, Ashley Plascencia, Rodolfo A. Salido, Phoebe Seaver, Elizabeth W. Smoot, Daniel McDonald, Robert M. Neuhard, Angela L. Scioscia, Alysson M. Satterlund, Elizabeth H. Simmons, Dismas B. Abelman, David Brenner, Judith C. Bruner, Anne Buckley, Michael Ellison, Jeffrey Gattas, Steven L. Gonias, Matt Hale, Faith Hawkins, Lydia Ikeda, Hemlata Jhaveri, Ted Johnson, Vince Kellen, Brendan Kremer, Gary Matthews, Ronald W. McLawhon, Pierre Ouillet, Daniel Park, Allorah Pradenas, Sharon Reed, Lindsay Riggs, Alison Sanders, Bradley Sollenberger, Angela Song, Benjamin White, Terri Winbush, Christine M. Aceves, Catelyn Anderson, Karthik Gangavarapu, Emory Hufbauer, Ezra Kurzban, Justin Lee, Nathaniel L. Matteson, Edyth Parker, Sarah A. Perkins, Karthik S. Ramesh, Refugio Robles-Sikisaka, Madison A. Schwab, Emily Spencer, Shirlee Wohl, Laura Nicholson, Ian H. McHardy, David P. Dimmock, Charlotte A. Hobbs, Omid Bakhtar, Aaron Harding, Art Mendoza, Alexandre Bolze, David Becker, Elizabeth T. Cirulli, Magnus Isaksson, Kelly M. Schiabor Barrett, Nicole L. Washington, John D. Malone, Ashleigh Murphy Schafer, Nikos Gurfield, Sarah Stous, Rebecca Fielding-Miller, Richard S. Garfein, Tommi Gaines, Cheryl Anderson, Natasha K. Martin, Robert Schooley, Brett Austin, Duncan R. MacCannell, Stephen F. Kingsmore, William Lee, Seema Shah, Eric McDonald, Alexander T. Yu, Mark Zeller, Kathleen M. Fisch, Christopher Longhurst, Patty Maysent, David Pride, Pradeep K. Khosla, Louise C. Laurent, Gene W. Yeo, Kristian G. Andersen, Rob Knight
Publikováno v:
Nature. 609:101-108
As SARS-CoV-2 continues to spread and evolve, detecting emerging variants early is critical for public health interventions. Inferring lineage prevalence by clinical testing is infeasible at scale, especially in areas with limited resources, particip
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224738 (2019)
Tissue-type plasminogen activator (tPA) is a major activator of fibrinolysis, which also attenuates the pro-inflammatory activity of lipopolysaccharide (LPS) in bone marrow-derived macrophages (BMDMs) and in vivo in mice. The activity of tPA as an LP
Externí odkaz:
https://doaj.org/article/dbae6326c2dd496aa07ae915b6be1442
Autor:
Frank B. Furnari, Webster K. Cavenee, Steven L. Gonias, Paul S. Mischel, Clark C. Chen, Amy Haseley Thorne, Scott R. VandenBerg, Donald Pizzo, Genaro R. Villa, Tiffany Taylor, German G. Gomez, Jingjing Hu, Jill Wykosky
Supplemental Figure S3. Suppression of Akt activation in resistant clones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c845e5a771cb5993c60fe09a7e8ba5fc
https://doi.org/10.1158/0008-5472.22407161.v1
https://doi.org/10.1158/0008-5472.22407161.v1
Autor:
Steven L. Gonias, Richard Klemke, Konstantin Stoletov, Drue L. Webb, Boryana M. Eastman, Minji Jo
Signaling by urokinase-type plasminogen activator receptor (uPAR) can cause epithelial-mesenchymal transition (EMT) in cultured breast cancer cells. In this report, we show that uPAR signaling can also induce cancer stem cell (CSC)–like properties.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5bce7c4734b7426e8a089ba0157a7d
https://doi.org/10.1158/0008-5472.c.6501198.v1
https://doi.org/10.1158/0008-5472.c.6501198.v1
Autor:
Steven L. Gonias, Richard Klemke, Konstantin Stoletov, Drue L. Webb, Boryana M. Eastman, Minji Jo
Supplementary Figure 1 from Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell–like Properties in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a34176ec20f4f063213b7229580c059
https://doi.org/10.1158/0008-5472.22385337
https://doi.org/10.1158/0008-5472.22385337